HDCN Online Slide/Audio Symposium    
American Society of Nephrology

Genzyme Therapeutics

Satellite Symposium of the American Society of Nephrology 32nd Annual Scientific Meeting, November, 1999
Genzyme Therapeutics, ASN Corporate Sponsor
Supported by an unrestricted grant from Genzyme Therapeutics

Consequences of Hyperphosphatemia: Are We Accepting the Unacceptable?
You need to REGISTER WITH HDCN (it's free) before you can access these talks. This program offers 1.5 hours of Category One CME Credit through the University of Minnesota. For CME-related information click here
The Talks

Role of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism
Eduardo Slatopolsky, M.D.


Acid-Base and the Skeleton
David Bushinsky, M.D.


Epidemiology and Quality Improvement in Phosphate Management
Glenn Chertow, M.D., M.P.H.


Questions and Answers
Drs. Slatopolsky, Bushinsky, and Chertow


Selected References
Compiled by course faculty

For more information, please see the 1998 ASN Satellite Symposium on Hyperphosphatemia. click here

Faculty

David Bushinsky, M.D., Professor of Medicine, Pharmacology, and Physiology; Chief, Nephrology Unit, University of Rochester Medical Center, Rochester, NY.

Glenn Chertow, M.D., M.P.H. Professor of Medicine, University of California at San Francisco, San Francisco, CA.

Eduardo Slatopolsky, M.D., Professor of Renal Diseases in Medicine, Washington University, St. Louis, MO

Back to symposia list by topic
Back to symposia list by meeting
Back to HDCN home page

HDCN